학술논문
6058 Phase I/II study of weekly intermittent capecitabine with bevacizumab and oxaliplatin on an every-2-week schedule for patients with untreated advanced colorectal cancer (CRC) final results
Document Type
Abstract
Author
Source
In EJC Supplements 2009 7(2):339-339
Subject
Language
ISSN
1359-6349